This Seminar presents the current best practice for the diagnosis and management of
bladder cancer. The scope of this Seminar ranges from current challenges in pathology …

Bladder cancer is a complex disease associated with high morbidity and mortality rates if not
treated optimally. Awareness of haematuria as the major presenting symptom is paramount …

Bladder cancer is a heterogeneous disease, with 70% of patients presenting with superficial
tumours, which tend to recur but are generally not life threatening, and 30% presenting as …

Context: Invasive bladder cancer is a frequently occurring disease with a high mortality rate
despite optimal treatment. The European Association of Urology (EAU) Muscle-invasive and …

Although muscle-invasive bladder cancer is commonly treated with radical cystectomy, a
standard alternative is bladder preservation therapy, consisting of maximum transurethral …

Context Invasive bladder cancer is a frequently occurring disease with a high mortality rate
despite optimal treatment. The European Association of Urology (EAU) Muscle-invasive and …

Importance Bladder cancer is a common malignancy in women and is the fourth most
common malignancy in men. Bladder cancer ranges from unaggressive and usually …

Bladder cancer is the second most common genitourinary tumour and is a significant cause
of morbidity and mortality. Trials of neoadjuvant and adjuvant chemotherapy have failed to …

The field of research in bladder cancer has seen significant advances in recent years. Next-
generation sequencing has identified the genes most mutated in bladder cancer. This …

Bladder cancer is the fourth most common cancer and ranks eighth as a cause of death from
cancer among men in the United States. Although guidelines assist in treatment, the art of …